会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Compositions for veterinary and medical applications
    • 兽医和医疗应用的组成
    • US08927565B2
    • 2015-01-06
    • US10570509
    • 2004-08-26
    • Betty JinWen-Yang Wu
    • Betty JinWen-Yang Wu
    • A61K31/4745A61K31/717A23K1/16A23K1/17A23K1/18A23L1/30A61K31/47A61K31/718A61K31/78
    • A61K31/717A23K20/132A23K20/195A23K50/30A23K50/75A23L33/105A61K31/47A61K31/718A61K31/78A61K2300/00
    • Compositions including polymeric dialdehydes and compounds of where R1, R2, R7, R8, R9, and R10 may be the same or different and are selected from H, CH3, OH, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl; R3, R4, R5, R6 may be the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl, or R5 and R6 are the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl and R3 and R4 together are ═O, or R4 and R6 are the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl and R3 and R5 together form a double bond or are ═O, or R3 and R4, are the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl and R5 and R6 together are ═O; R11 and R12 together form ═CH2, or R11 and R12 may be the same or different and are independently selected from the group consisting of H, CH3, CH2CH3 and CH2CH2CH3; and X is selected from the group consisting of Cl, Br, SO4, I and R13COO, where R13 is CH3 or poly acids, for the treatment of gastrointestinal functional disorders or related conditions as well as for the promotion of general health and weight gain in animals including humans.
    • 包括聚合二醛和其中R 1,R 2,R 7,R 8,R 9和R 10可以相同或不同并且选自H,CH 3,OH,OCH 3,C 2 H 5,OC 2 H 5 OCH 2 Ph,OCH 2 PhNO 2,F或Cl的化合物的组合物; R 3,R 4,R 5,R 6可以相同或不同,选自H,CH 3,OCH 3,C 2 H 5,OC 2 H 5 OCH 2 Ph,OCH 2 PhNO 2,F或Cl,或R 5和R 6相同或不同,选自H, OCH 3,C 2 H 5,OC 2 H 5 OCH 2 Ph,OCH 2 PhNO 2,F或Cl和R 3和R 4一起为=或者R 4和R 6相同或不同,并且选自H,CH 3,OCH 3,C 2 H 5,OC 2 H 5 OCH 2 Ph,OCH 2 PhNO 2,F或Cl和R 3 并且R 5和R 5一起形成双键,或者是=或者R 3和R 4相同或不同,并且选自H,CH 3,OCH 3,C 2 H 5,OC 2 H 5 OCH 2 Ph,OCH 2 PhNO 2,F或Cl和R 5和R 6一起是= R 11和R 12一起形成= CH 2,或者R 11和R 12可以相同或不同,并且独立地选自H,CH 3,CH 2 CH 3和CH 2 CH 2 CH 3; X选自Cl,Br,SO 4,I和R 13 COO,其中R 13为CH 3或多酸,用于治疗胃肠功能障碍或相关病症,以及促进一般健康和体重增加 动物包括人类。
    • 9. 发明申请
    • Compositions for veterinary and medical applications
    • US20070027176A1
    • 2007-02-01
    • US10570509
    • 2004-08-26
    • Betty JinWen-Yang Wu
    • Betty JinWen-Yang Wu
    • A61K31/4745
    • A61K31/717A23K20/132A23K20/195A23K50/30A23K50/75A23L33/105A61K31/47A61K31/718A61K31/78A61K2300/00
    • This invention is related to compositions including compounds of where R1, R2, R7, R8, R9, and R10 may be the same or different and are selected from H, CH3, OH, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl; R3, R4, R5, R6 may be the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl, or R5 and R6 are the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl and R3 and R4 together are ═O, or R4 and R6 are the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl and R3 and R5 together form a double bond or are ═O, or R3 and R4, are the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl and R5 and R6 together are ═O; R11 and R12 together form ═CH2, or R11 and R12 may be the same or different and are independently selected from the group consisting of H, CH3, CH2CH3 and CH2CH2CH3; and X is selected from the group consisting of Cl, Br, SO4, I and R13COO, where R13 is CH3 or poly acids, and/or compounds of Formula (2) wherein each of the monomers Rp and Rr, are independently selected from the group consisting of: and each monomer Rq is independently selected from the group consisting of: wherein each R14 may be the same or different and is independently selected from the group consisting of CH2OH, COOH, CH2OCH2COOH and CH2OR15, where R15 is selected from the group consisting of CH2C6H4COOH, C6H4COOH and CH2(CH2)yCOOH where y=1 to 20; wherein p1 - - - pn may be the same or different and are each independently selected from the range 0 to n; q1 - - - qn may be the same or different and are each independently selected from the range 1 to m; r1 - - - rn may be the same or different and are each independently selected from the range of 0 to n, n is an integer greater than 0 and m is an integer greater than 1; and wherein   ⁢ q 1 + ⋯ + q n p 1 + ⋯ + p n + q 1 + ⋯ + q n + r 1 + ⋯ + r n ⨯ 100 ⁢ % ≥ 30 ⁢ % for the treatment of gastrointestinal functional disorders or related conditions; as well as for the promotion of general health and weight gain in animals including humans.
    • 10. 发明授权
    • Dimeric inhibitors of influenza neuraminidase
    • 流感神经氨酸酶二聚体抑制剂
    • US06548476B1
    • 2003-04-15
    • US09658445
    • 2000-09-08
    • Wen-Yang WuBetty Jin
    • Wen-Yang WuBetty Jin
    • A61K3116
    • C07D309/28A61K31/00A61K31/351A61K47/54A61K47/55A61K47/59A61K47/595A61K47/60
    • This invention relates to novel dimeric compounds, methods for their preparation, pharmaceutical formulations thereof, and their use as antiviral agents. The compounds are particularly useful against influenza virus. In particular the invention provides a dimeric compound which comprises two neuraminidase binding groups attached to a spacer or linking group. Preferably the dimeric molecule comprises two neuraminidase-binding neuraminic acid (sialic acid) or cyclopentyl or cyclohexenyl carboxylic acid derivatives covalently attached to a common spacer group. Pharmaceutical compositions and methods of treatment, prophylaxis and diagnosis are disclosed and claimed.
    • 本发明涉及新的二聚化合物,其制备方法,其药物制剂及其作为抗病毒剂的用途。 该化合物特别适用于流感病毒。 特别地,本发明提供了一种二聚化合物,其包含连接到间隔基或连接基团的两个神经氨酸酶结合基团。 优选地,二聚体分子包含共价连接到共同间隔基团上的两种神经氨酸酶结合神经氨酸(唾液酸)或环戊基或环己烯基羧酸衍生物。 公开和要求保护药物组合物和治疗,预防和诊断方法。